0001288123-17-000028.txt : 20170703 0001288123-17-000028.hdr.sgml : 20170703 20170703112312 ACCESSION NUMBER: 0001288123-17-000028 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170629 FILED AS OF DATE: 20170703 DATE AS OF CHANGE: 20170703 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AGENUS INC CENTRAL INDEX KEY: 0001098972 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 061562417 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3 FORBES ROAD CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 781-674-4410 MAIL ADDRESS: STREET 1: 3 FORBES ROAD CITY: LEXINGTON STATE: MA ZIP: 02421 FORMER COMPANY: FORMER CONFORMED NAME: ANTIGENICS INC /DE/ DATE OF NAME CHANGE: 19991115 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: WIINBERG ULF CENTRAL INDEX KEY: 0001187314 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-29089 FILM NUMBER: 17944589 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2017-06-29 0 0001098972 AGENUS INC agen 0001187314 WIINBERG ULF 1 0 0 0 Deferred Shares 3.583 2017-06-30 4 A 0 4709.928 3.583 A Common Stock 4709.928 4709.928 D Stock Option, Roght to buy 3.91 2017-06-29 4 A 0 50000 3.91 A 2018-06-29 2027-06-29 Common Stock 50000 50000 D Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company. Annual option award vesting 100% on the earlier of the grant date of the award or the date of the Company's 2018 annual shareholder meeting. Christine M. Klaskin, by Power of Attorney 2017-07-03